Target intelligence / Profile preview

Coenzyme Q–cytochrome c reductase (Complex III)

Target
Complex III
Molecular classification
Enzyme, Transmembrane protein complex, Multi-subunit protein assembly
01

Overview

Coenzyme Q–cytochrome c reductase (Complex III) is a multi-subunit enzyme complex embedded in the inner mitochondrial membrane that catalyzes the transfer of electrons from ubiquinol (CoQH2) to cytochrome c via the Q-cycle, coupling this transfer to proton translocation from the mitochondrial matrix to the intermembrane space. This process creates the electrochemical gradient necessary for ATP synthesis by ATP synthase (Complex V). Complex III consists of cytochrome b (encoded by mtDNA), cytochrome c1, Rieske iron-sulfur protein, and at least eight additional subunits. Dysfunction or inhibition of Complex III impairs cellular energy production, increases ROS generation, and triggers apoptosis or cell stress responses. Mutations in its subunits, especially cytochrome b, are associated with mitochondrial diseases. Complex III is a target for research drugs that explore mechanisms of cell death, oxidative stress, and metabolism, but interference in its function carries risks of toxicity and systemic mitochondrial dysfunction.

Other names
Cytochrome bc1 complexCoQ–cytochrome c reductaseUbiquinol–cytochrome c oxidoreductaseCIIIMitochondrial complex III
02

Mechanism of action

Inhibition of electron transfer (prevents Q-cycle, collapses proton gradient); Disruption of ATP synthesis (by blocking proton pumping); Induction of mitochondrial ROS (leading to cell apoptosis or stress response)

03

Biological functions

Electron transfer in mitochondrial respirationProton pumping across inner mitochondrial membraneGeneration of proton electrochemical gradient for ATP synthesisSuperoxide and reactive oxygen species (ROS) generationApoptosis regulationCell signaling (oxygen sensing, hypoxia response)
04

Disease associations

Mitochondrial diseaseCardiovascular diseaseNeurodegenerative diseaseCancerInflammationOther: Potential involvement in infection and immune response
05

Safety considerations

Oxidative stress and tissue damageSystemic toxicityOff-target effectsInduction of cell death/apoptosis
06

Interacting drugs

Antimycin A

3 more in the full profile.

07

Biomarkers

Elevated ROS levelsCytochrome c releaseComplex III enzyme activitymtDNA mutations in cytochrome b

Beyond the preview

Go deeper on Coenzyme Q–cytochrome c reductase (Complex III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coenzyme Q–cytochrome c reductase (Complex III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call